Skip to main content
Molecular Endocrinology logoLink to Molecular Endocrinology
. 2011 Dec 1;26(1):153–164. doi: 10.1210/me.2011-1207

The Expression and Role of Hyperpolarization-Activated and Cyclic Nucleotide-Gated Channels in Endocrine Anterior Pituitary Cells

Karla Kretschmannova 1, Marek Kucka 1, Arturo E Gonzalez-Iglesias 1, Stanko S Stojilkovic 1,
PMCID: PMC3248322  PMID: 22135067

Abstract

Pituitary cells fire action potentials independently of external stimuli, and such spontaneous electrical activity is modulated by a large variety of hypothalamic and intrapituitary agonists. Here, we focused on the potential role of hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels in electrical activity of cultured rat anterior pituitary cells. Quantitative RT-PCR analysis showed higher level of expression of mRNA transcripts for HCN2 and HCN3 subunits and lower expression of HCN1 and HCN4 subunits in these cells. Western immunoblot analysis of lysates from normal and GH3 immortalized pituitary cells showed bands with appropriate molecular weights for HCN2, HCN3, and HCN4. Electrophysiological experiments showed the presence of a slowly developing hyperpolarization-activated inward current, which was blocked by Cs+ and ZD7288, in gonadotrophs, thyrotrophs, somatotrophs, and a fraction of lactotrophs, as well as in other unidentified pituitary cell types. Stimulation of adenylyl cyclase and addition of 8-Br-cAMP enhanced this current and depolarized the cell membrane, whereas 8-Br-cGMP did not alter the current and hyperpolarized the cell membrane. Both inhibition of basal adenylyl cyclase activity and stimulation of phospholipase C signaling pathway inhibited this current. Inhibition of HCN channels affected the frequency of firing but did not abolish spontaneous electrical activity. These experiments indicate that cAMP and cGMP have opposite effects on the excitability of endocrine pituitary cells, that basal cAMP production in cultured cells is sufficient to integrate the majority of HCN channels in electrical activity, and that depletion of phosphatidylinositol 4,5-bisphosphate caused by activation of phospholipase C silences them.


Pituitary cells fire action potentials (AP) independently of external stimuli, a phenomenon termed “spontaneous electrical activity.” Each AP is composed of a slow depolarizing phase, a rapid depolarizing phase or spiking depolarization, and a rapid or delayed (plateau-bursting type) repolarizing phase (1). Such rhythmicity fulfills the need to drive the periodic fluctuations in cytosolic Ca2+ concentrations and hormone release, as is well documented for lactotrophs and somatotrophs (2). In general, intrinsic electrophysiological characteristics of neuronal, neuroendocrine, and muscle cells reflect the type and density of numerous voltage- and ligand-gated ion channels that regulate the flow of ionic currents across the plasma membrane (3). In that respect, it is not unexpected that endocrine pituitary cells also possess a rich repertoire of ion channels, including voltage-gated Na+, K+, and Ca2+ channels, ligand-gated GABAγ-aminobutyric acid-A, and purinergic P2X receptor channels, as well as a number of less conventional ionic conductances. Spontaneous electrical activity of these cells is modulated by a large variety of hypothalamic and intrapituitary agonists and intracellular messenger systems. These include agonists for the G protein-coupled receptors; the Gs-coupled receptors (CRH, GHRH, vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide) facilitate firing of AP, the Gi/o-coupled receptors (dopamine and somatostatin) inhibit it, and the Gq/11-coupled receptors (GnRH, TRH, arginine vasopressin) have dual roles, an initial inhibitory and a sustained stimulatory role (1).

In neurons and cardiac cells, the ionic channels that generate autonomous pacemaking capabilities are frequently members of the small family of pacemaking channels. These channels, termed “hyperpolarization-activated and cyclic nucleotide-gated” (HCN) channels, belong to the superfamily of voltage-gated channels but form a distinct subgroup of channels that are closely related to voltage-independent cyclic nucleotide-gated (CNG) channels (4). Unique voltage dependence of HCN channels, together with permeability for both K+ and Na+, explains their pacemaking function in cardiac tissue (5, 6). HCN and CNG channels also play important roles in spontaneous and receptor-induced excitability of other cells by increasing the slope of slow depolarization. This comes from their regulatory properties. The hyperpolarization-activated cation current, termed “Ih” (h stands for hyperpolarization), is sensitive to the presence of cAMP and, to a much weaker extent, cGMP. Cyclic nucleotides not only accelerate the kinetics of activation of Ih, but also shift the voltage dependence for activation toward more depolarized values. On the other hand, CNG channels expressed in photoreceptors have a strong preference for cGMP, whereas the olfactory channel is almost equally sensitive to both ligands (4). The dependence of HCN and CNG channel activation on cyclic nucleotides provides a rationale for the stimulatory effects of Gs-coupled receptors and nitric oxide-soluble guanylyl cyclase signaling pathways on the electrical activity in excitable cells. The Gi/o-dependent inhibitory actions on cAMP-mediated regulation of Ih have also been documented (7). The Gq/11-coupled receptors also influence the gating of HCN and CNG channels by affecting the phosphatidylinositol 4,5-bisphosphate (PIP2) levels (8).

To date, four mammalian channel subunits, termed “HCN1–4,” have been cloned. These subunits, organized as homo- and heterotetrameric complexes, represent the molecular correlates of the Ih (9, 10). The pharmacological identification of these channels is based on the sensitivity to several inhibitors, including ZD7288 and extracellular Cs+, and insensitivity to extracellular Ba2+ (11, 12). In vertebrates, there are six CNG subunits: CNGA1, CNGA2, CNGA3, CNGA4, CNGB1, and CNGB3. CNGA1–3 subunits can form homomeric channels in heterologous expression systems, and the other subunits can coassemble to form functional heteromeric channels (4). The mRNA transcripts and functional HCN channels were identified in rat GH3 cells and somatotrophs (1315), mouse At-T20 cells (16), and frog melanotrophs (17), but the expression and role of HCN channels in electrical activity in other endocrine pituitary cells were not studied. The mRNA transcripts for CNG channels were also identified in rat pituitary cells (18), whereas the dependence of pituitary cell excitability on cAMP vs. cGMP was not clarified. The influence of the Gq/11 signaling pathway on the activity of these channels was also not studied.

Here we focus on the expression and role of HCN channels in electrical activity in cultured somatotrophs, gonadotrophs, lactotrophs, and thyrotrophs. The biophysical properties of Ih were systematically investigated in these cell types, including the slow kinetics and voltage dependence of their activation and the lack of inactivation. We also examined the pharmacological properties of these channels. Because there is not a common Gs-coupled receptor among these cells, we used forskolin, an activator of adenylyl cyclase, and cell-permeable 8-Br-cAMP and 8-Br-cGMP to activate these channels. Similarly, we down-regulated basal cAMP production and cAMP-dependent channel activity by inhibiting adenylyl cyclase. We also used pharmacological manipulations to alter the status of phospholipase C activity and levels of phosphoinositides. Single cell recordings were used in electrophysiological studies, and cyclic nucleotides were measured in mixed pituitary cell populations.

Results

Effects of cyclic nucleotides on electrical activity in anterior pituitary cells

In secretory anterior pituitary cells, both forskolin and cAMP stimulate electrical activity. Figure 1, A and E, shows stimulatory effects of cell permeable 8-Br-cAMP on electrical activity in thyrotrophs and gonadotrophs, respectively, and Fig. 1D shows effect of forskolin on electrical activity in gonadotrophs. In contrast to the depolarizing effect of 8-Br-cAMP, 8-Br-cGMP hyperpolarized the plasma membrane in thyrotrophs (Fig. 1, B and C), which slowed the firing frequency in spontaneously firing cells (Fig. 1B). Similar effect of 8-Br-cGMP was also observed in other pituitary cell types. In addition, an 85-fold increase in cGMP production was caused by a 30-min incubation with 10 μm 3,3′-(hydroxynitrosohydrazino)bis-1-propanamine, a nitric oxide donor (basal cGMP was at 44 ± 8 fmol/well, n = 6, 3,3′-(hydroxynitrosohydrazino)bis-1-propanamine-stimulated cGMP was at 3.77 ± 0.1 pmol/well, n = 6). However, this incubation was still unable to stimulate electrical activity in anterior pituitary cells (data not shown). These results indicate that HCN channels, but not CNG channels, could account for cAMP-stimulated electrical activity in endocrine pituitary cells, whereas cGMP inhibits electrical activity through other channels.

Fig. 1.

Fig. 1.

Expression of HCN cation channels in rat pituitary cells. A–C, Effects of 8-Br-cAMP (A) and 8-Br-cGMP (B and C) on electrical activity in thyrotrophs. Note both the depolarizing effect of cAMP and the hyperpolarizing effect of 8-Br-cGMP. D and E, Forskolin-(D) and 8-Br-cAMP-stimulated (E) stimulated electrical activity in pituitary gonadotrophs. F, Quantitative RT-PCR analysis of HCN subunit mRNA transcript expression in anterior pituitary cells cultured for 24 h. G, Western blot analysis of HCN expression in primary and GH3 immortalized pituitary cells. s, Seconds.

Expression of HCN channels

To clarify the expression of HCN channels in endocrine pituitary cells, we performed quantitative RT-PCR analysis. This analysis confirmed the presence of mRNA transcripts for HCN1, HCN2, HCN3, and HCN4 in mixed populations of rat anterior pituitary cells cultured for 24 h. The real-time quantitative PCR and the comparative Ct method (19) also revealed that HCN2 mRNA transcripts are the most abundantly expressed, followed by HCN3, HCN4, and HCN1 (Fig. 1F). The presence of HCN isoforms was also studied in mixed rat pituitary cells and GH3 immortalized lactosomatotrophs using Western blot analysis. We were unable to detect any specific band using HCN1 antibodies. In contrast, double immunoreactive bands for HCN2 and HCN3 were detected, consistent with the presence of glycosylated and nonglycosylated forms, whereas HCN4 subunit was observed as a single immunoreactive band (Fig. 1G). Moreover, all immunopositive bands appeared at different molecular weights, and their positions were in good agreement with earlier data obtained from other tissues expressing HCN channels (20, 21). Finally, rat liver tissue was used as negative control as no mRNA expression of HCN isoforms was detected (results not shown), in accordance with earlier published data (20, 21).

Biophysical characterization of native HCN channels

Experiments were performed in cultured single pituitary cells 24 h after dispersion. Somatotrophs were identified by their responses to GHRH. As recently described, these cells respond with variable patterns of electrical activity (22). Figure 2 shows that GHRH induced single spiking in a quiescent somatotroph (panel A) and increased the frequency of plateau-bursting type of electrical activity in a spontaneously active cell (panel B). Both lactotrophs and thyrotrophs express TRH receptors, but in contrast to lactotrophs, thyrotrophs do not express dopamine D2 receptors. Figures 3A and 4A, show the pattern of electrical activity triggered by TRH in lactotrophs and thyrotrophs, respectively; the former also responded to the application of bromocriptine, a dopamine D2 agonist, by hyperpolarization of the plasma membrane (Fig. 3A, bottom). Note that TRH triggered electrical activity with the peak AP amplitude reaching +30 to +40 mV in thyrotrophs (Fig. 4A), whereas AP overshooting was not observed in lactotrophs (Fig. 3A). Gonadotrophs were identified by their oscillatory and apamin-sensitive response to 1 nm GnRH (23, 24) (Fig. 5A). Cells not responding to these agonists were described as unidentified.

Fig. 2.

Fig. 2.

Characterization of Ih current in pituitary somatotrophs. A and B, Identification of somatotrophs by GHRH-induced electrical activity in a quiescent cell (A) and modulation of the frequency of AP in a spontaneously active cell (B). C, Representative example of the whole-cell current response to a hyperpolarizing voltage step to −120 mV from a holding potential of −40 mV. D, In all somatotrophs (S), the channel opening was best described by a single-exponential fit. In gonadotrophs (G), lactotrophs (L), and thyrotrophs (T), both single- and double-exponential developments of current were observed. E, Activation curve for Ih. Tail current measurements were used. Cells were held at a holding potential of −40 mV and pulsed in 20-mV increments to test potentials between −60 and −120 mV for 7.5 sec. Normalized amplitudes of tail currents I/Imax were plotted against testing voltage and fitted with the Boltzmann equation (see “Calculations”). Averaged data (means ± sem) from seven cells are shown. F and G, Representative traces of Ih current before and 10 min after addition of 100 μm ZD7288 (F) and before and after application of 1 mm Cs+ (G) for 30 sec. H, Reduction in AP frequency by 1 mm Cs+ in a spontaneously firing cell expressing Ih current. s, Seconds.

Fig. 3.

Fig. 3.

Characterization of Ih current in rat pituitary lactotrophs. A, Lactotrophs were identified by their sensitivity to TRH (top) and bromocriptine (bottom). B and D, Whole-cell voltage-clamp recordings of Ih in identified lactotrophs in the presence (gray) and absence (black) of 1 mm Cs+ (B) and ZD7288 (D). C, The majority of lactotrophs do not express Ih (top) or show small amplitude current response (middle). Only about 30% of lactotrophs express Ih with amplitude comparable to other anterior pituitary cells (bottom). E, The activation curve for Ih obtained by tail current analysis. F (main panel), Dose-dependent effects of MDL12330A, an adenylyl cyclase inhibitor, on cAMP release in a mixed population of pituitary cells. Inset, Bath application of MDL12330A reduced the amplitude of Ih in an identified lactotroph.

Fig. 4.

Fig. 4.

Characterization of Ih current in rat pituitary thyrotrophs. Panel A, Thyrotrophs were identified by their response to TRH and their lack of response to bromocriptine. Note the difference in the peak amplitude of AP in thyrotrophs and lactotrophs (Figs. 3A vs. 4A). Panel B, Representative example of the whole-cell current response to a hyperpolarizing voltage step to −120 mV from a holding potential of −40 mV. The time course of channel opening was best described by a double-exponential fit. Panel C, Inhibition of Ih current by 10 μm ZD7288. D, Stimulation of Ih by 8-Br-cAMP. E, Inhibition of Ih by MDL12230A. Top, Representative trace; bottom, Normalized current- and time-constant (τ) values (mean ± sem).s, Seconds; C, control.

Fig. 5.

Fig. 5.

Properties of HCN channels in pituitary gonadotrophs. A, Cells were identified by their oscillatory response to 1 nm GnRH applied at the end of the recording. B, Representative example of the whole-cell current response to a hyperpolarizing voltage step to −120 mV from a holding potential of −40 mV. The time course of channel opening was best described by a single-exponential fit. C, The activation curve for Ih was obtained by tail current analysis as described in Fig. 2E. D, Blockade of Ih current by the addition of 100 μm ZD7288 to extracellular solution. ZD7288 was applied to the bath for 10 min to fully develop its blocking effect. E, Inhibition of Ih by 1 mm bath Cs+. F and G, Cells expressing Ih (F, bottom) displayed inward rectifications in response to hyperpolarizing current pulses of −5 pA that were suppressed by 1 mm Cs+ (F, top) and were absent (G, top) in cells lacking Ih (G, bottom). H and I, Difference in the effects of bath Cs+ on the frequency of spontaneous firing of AP in gonadotrophs expressing (H) and not expressing (I) Ih. Percentage decrease (H, downward arrow) or increase (I, upward arrow) in frequency is indicated for each cell group. s, Seconds.

In these cell types, the hyperpolarization of the plasma membrane resulted in activation of a slowly developing inward current in endocrine pituitary cells held at −40 mV and bathed in medium containing 20 mm K+. The current started to appear at voltages approaching −60 mV, and both the amplitude and the rate of activation of this current increased with further hyperpolarization. Representative examples of the whole-cell current response to a hyperpolarizing voltage step to −120 mV from a holding potential of −40 mV are shown in Fig. 2C (somatotrophs), Fig. 3C (lactotrophs), Fig. 4B (thyrotrophs), and Fig. 5B (gonadotrophs). Such currents were observed in the majority of somatotrophs, thyrotrophs, and gonadotrophs (Table 1), as well as in unidentified pituitary cells (data not shown). In contrast, the majority of lactotrophs do not express Ih (Fig. 3C, top) or show small amplitude current response (middle), whereas only about 30% of lactotrophs expresses currents with amplitudes comparable to that recorded from somatotrophs and gonadotrophs (Fig. 3C, bottom; Table 1).

Table 1.

Biophysical properties of Ih in anterior pituitary cells

Gonadotrophs Lactotrophs Somatotrophs Thyrotrophs
Cells with Ih (%) 73.8 33.3 92.3 81.3
Amplitude (pA) 6.4 ± 0.7 (45) 8.5 ± 2.2 (31) 6.6 ± 1.1 (36) 15.9 ± 3.4 (8)
Amplitude (pA/pF) 1.1 ± 0.1 (43) 1.5 ± 0.4 (31) 1.7 ± 0.3 (35) 2.8 ± 0.6 (8)
τ (s) 0.9 ± 0.2 (38) 1.2 ± 0.2 (25) 1.7 ± 0.1 (35) 1.2 ± 0.2 (7)

The Ih was augmented by elevation of K+ in extracellular solution to 20 mm before recording. The Ih current was activated by voltage steps from −40 to −120 mV. Data shown are mean ± sem values and number in parentheses indicate number of cells.

The increase in current in somatotrophs was always fit best with a single-exponential function, whereas in other cell types the best approximation for the increase in current was achieved using single- or double-exponential fits with a time constant of activation ranging between 0.15 and 5 sec (Fig. 2D). The development of current was fastest in gonadotrophs and slowest in somatotrophs. The peak amplitude of current was comparable in gonadotrophs, lactotrophs, and somatotrophs and was doubled in thyrotrophs (Table 1). The currents did not inactivate significantly during the sustained application of a hyperpolarizing pulse (5–7 sec) but did deactivate rapidly after the end of the pulse.

Using the tail current measurements, we also obtained the activation curve of the Ih current in somatotrophs (Fig. 2E), lactotrophs (Fig. 3E), and gonadotrophs (Fig. 5C). In somatotrophs, a mean V1/2 value of −93.2 ± 3.4 mV and a slope value of 9.3 ± 1.1 mV (n = 7), in lactotrophs a V1/2 value of −94.1 ± 2.7 mV and a slope value of 8.6±1.2 mV (n = 4), and in gonadotrophs a V1/2 value of −83.2 ± 3.3 mV and a slope value of 8.3 ± 1.2 mV were recorded. Such kinetic properties of the hyperpolarization-activated inward currents in anterior pituitary cells were similar to the properties of Ih currents present in neuronal and cardiac cells (11) as well as in GH3 pituitary cells (13, 14).

Pharmacological characterization of native HCN channels

In all cell types, the current development was blocked by 100 μm ZD7288, an organic blocker of Ih (25, 26), and by 1 mm Cs+-containing medium. Consistent with the literature, the inhibitory effect of Cs+ in our experiments was instantaneous and reversible, whereas ZD7288 had to be applied for 10 min to achieve full and irreversible inhibition of this current. Effects of ZD7288 on the current amplitude are shown in somatotrophs (Fig. 2F), lactotrophs (Fig. 3D), thyrotrophs (Fig. 4C), and gonadotrophs (Fig. 5D). The effect of ZD7288 on the current did not differ between cell types. In gonadotrophs, ZD7288 inhibited 86 ± 6% (n = 4) of the current when applied at 100 μm concentration for 10 min, 62 ± 5% at 10 μm concentration for 10 min (n = 7), and 34 ± 4% when applied at 10 μm concentration for 5 min (n = 6). Effects of 1 mm Cs+ on the Ih amplitude are shown in Figs. 2G, 3B, and 5E. In all cell types, Cs+ (1 mm) inhibited 98 ± 1% of current when applied for 30 sec (n = 16). Gonadotrophs expressing Ih (Fig. 5F, bottom) displayed inward rectifications in response to hyperpolarizing current pulses of −5 pA that were suppressed by 1 mm Cs+ (5F, top) and were absent (5G, top) in cells lacking Ih (5G, bottom). Similar effects of Cs+ were observed in the three other cell types (data not shown).

Because of the nonspecific stimulatory effect of ZD7288 on electrical activity in pituitary cells described earlier (27), we could not use this compound in evaluating the role of HCN channels in spontaneous electrical activity. Application of 1 mm Cs+ not only inhibits HCN channels effectively, but also silences spontaneously active inward rectifier K+ channels in many cell types, including pituitary cells (28, 29). Consistent with the second effect, we observed an increase in the firing frequency of 26 ± 13% in cells not expressing Ih (n = 13). Figure 5I illustrates the stimulatory effect of 1 mm Cs+ on the firing frequency in a gonadotroph (n = 17) in which no Ih current was detected (5I, bottom). Figures 2H and 5H illustrate inhibitory effects of Cs+ on the firing frequency of Ih-expressing somatotrophs and gonadotrophs, respectively. Nonetheless, 1 mm Cs+ did not abolish spontaneous firing of AP in any of the cells expressing Ih. The effect of Cs+-induced inhibition of HCN channels on the frequency of AP is probably more pronounced but may be masked by its concomitant inhibition of classical inward rectifier K+ channels, which are also expressed in pituitary cells (28, 29). Notwithstanding, these results suggest that HCN channels contribute to, but are not critical for, spontaneous electrical activity in cultured pituitary cells.

Regulation of HCN channels

The ability of Cs+ to decrease the firing frequency suggested that basal cAMP levels in cultured pituitary cells are sufficient to activate these channels. To clarify this hypothesis, we treated pituitary cells with MDL12330A (cis-N-(2-phenylcyclopenthyl)azacyclotridec-1-en-2amine HCl), an inhibitor of the adenylyl cyclase family of enzymes. Figure 3F, main panel, illustrates the concentration-dependent effect of MDL12330A on basal cAMP production in cultured pituitary cells. MDL12330A (75 μm) also had a pronounced effect on Ih in lactotrophs (Fig. 3F, inset), thyrotrophs (Fig. 4E, top) and other pituitary cell types (data not shown). Figure 4E (bottom) illustrates that the current amplitude was reduced by 53 ± 8% (P < 0.0005, n = 10), and the current development was delayed for 222 ± 30% (P < 0.005, n = 9) in thyrotrophs treated with MDL12330A. The activation curve for Ih current was also measured before and after MDL12330A application. MDL12330A shifted the V1/2 of activation curve to the left (before MDL12330A: −92.5 ± 0.8 mV; after MDL12330A: −105.8 ± 5 .9 mV) without change in slope factor (s) (s = 7.8 ± 1.8 mV, before MDL12330A; s = 7.7 ± 1.0 mV, after MDL12330A).

Because there is not a common Gs-coupled receptor among these cells, we studied effects of forskolin, an activator of adenylyl cyclase, and 8-Br-cAMP, a cell-permeable cAMP analog, on the peak amplitude of Ih and the rate of current development. Ih was measured before (control) and approximately 5 min after application of 1 μm forskolin or 1 mm 8-Br-cAMP. In contrast to MDL12330A treatment, forskolin slightly but significantly increased the current amplitude (111 ± 3% of control, P < 0.01, n = 7) and facilitated development of current (τ = 66 ± 8% of control, P < 0.005; n = 7). 8-Br-cAMP also increased the amplitude of Ih to 112 ± 6% of control and decreased the τ to 66 ± 9% of control (n = 7). In particular, the effect of 8-Br-cAMP on the amplitude of Ih was rather minor in somatotrophs (3.4% increase) and much greater in gonadotrophs (14.8%) and thyrotrophs (36.8%; Fig. 4D), whereas 8-Br-cAMP-induced decrease of τ was comparable among these different cell types. These results indicate that basal cAMP production in pituitary cells in vitro is sufficient to activate HCN channels and that forskolin can further facilitate gating of these channels. Difference in the sensitivity of Ih to modulation by cAMP could reflect the cell type-specific expression of different HCN subunits and/or variations in basal cAMP production among subpopulations of pituitary cells.

In gonadotrophs, we consistently observed attenuation of Ih current after application of GnRH (1 nm; Fig. 6D) that could be only slightly recovered by application of forskolin or 8-Br-cAMP (data not shown). On average (n = 16), GnRH decreased the peak amplitude of Ih to 76 ± 6% of control (P < 0.0005) and increased τ to 228 ± 39% (P < 0.005). The GnRH receptor belongs to the Gq/11 family of G proteins and is coupled to phospholipase C. Because it has been shown that HCN channels are allosterically modulated by phosphoinositides, we tested the sensitivity of pituitary HCN channels to phosphoinositides by inhibiting the activity of phosphoinositide 3-kinase, the enzyme responsible for their synthesis. Treatment of pituitary cells with the phosphoinositide 3-kinase inhibitor wortmannin (10 μm for >10 min) decreased the Ih current amplitude to 83 ± 5% of controls (P < 0.05) and increased the τ value to 190 ± 23% (P < 0.01; n = 8), regardless of pituitary cell type (Fig. 6, A–C). Furthermore, direct activation of phospholipasec by m-3M3FBS [2,4,6-trimethyl-N-C3-(trifluromethyl)phenylybenzesulfo-nomide] (50 μm) strongly attenuated Ih current in pituitary gonadotrophs (Fig. 6E). Based on these data, we concluded that Ih current is regulated by phosphoinositides in pituitary cells.

Fig. 6.

Fig. 6.

Regulation of HCN channels by phosphoinositides in gonadotrophs and somatotrophs. A–C, Inhibitory effects of wortmannin, a phosphatidylinositol-3 and phosphatidylinositol-4 kinase inhibitor, on Ih in pituitary cells. Representative traces from somatotrophs (A) and gonadotrophs (B) and mean values of amplitude of Ih and τ in both cell types (n = 8). D and E, Inhibition of Ih by 1 nm GnRH (D) and 50 μm m-3M3FBS [2,4,6-trimethyl-N-C3-(trifluoromethyl)phenylybenzesulfo-nomide], a phospholipase C activator (E), in gonadotrophs. s, Seconds; WT, wortmannin.

Discussion

It is well established that cyclic nucleotides can modulate electrical activity through cAMP/cGMP-dependent kinases that phosphorylate several channels, including the background K+ conductance in corticotrophs (30, 31), voltage-gated K+ channels (32), L- and T-type voltage-gated Ca2+ channels (3335), tetrodotoxin-sensitive (36) and -resistant voltage-gated Na+ channels in somatotrophs (37), and transient receptor potential type C channels in all endocrine pituitary cells (38). Cyclic nucleotides could also modulate electrical activity in excitable cells by activation of CNG and HCN channels. Such a paradoxical role for these channels comes from their permeability properties (CNG are practically nonselective cation channels, and HCN channels are weakly K+-selective channels) and unique voltage dependence of HCN channels. Both second messengers contribute to regulation of CNG channels, with cAMP being more potent than cGMP in regulation of HCN channels (1).

Pituitary cells express a very sophisticated nitric oxide-synthase-soluble guanylyl cyclase signaling pathway (3941). The mRNA transcripts for CNG channels were also found in a mixed population of pituitary cells (18). Should such transcripts be translated to their protein products, activation of these channels should stimulate firing of AP. However, here we show that the application of 8-Br-cGMP caused the reverse effect on the excitability of pituitary cells for these channels: it hyperpolarized the plasma membrane and decreased the firing frequency, in contrast to cAMP, which depolarized the plasma membrane and stimulated firing of AP. The inhibitory effect of cGMP on electrical activity is consistent with a role of protein kinase G in the regulation of BK-type Ca2+-controlled K+ channels (42). These channels are expressed in all endocrine pituitary cells, and their activation leads to inhibition of spontaneous electrical activity (43). Thus, cGMP plays an opposite role in the control of excitability of endocrine pituitary cells compared with cAMP, which is consistent with the inhibitory effect of nitric oxide signaling pathway on hormone release by cultured pituitary cells (4446). Effects of NO/cGMP in intact pituitary gland are not only related to the electrical status of endocrine cells, but also may affect pituitary blood flow rates and oxygen supply by capillaries, as well as oxygen consumption (47, 48).

Previous studies have also described the expression of the HCN1 subunit and Ih in immortalized AtT-20 pituitary cells (tumor-derived mouse corticotrophs), which were weakly modulated by forskolin (16). The Ih was also identified in immortalized rat lactosomatotroph GH3 cells and cultured rat somatotrophs (13, 14) but forskolin-induced changes in the properties of the Ih current were not observed. Here, we show that transcripts for all four HCN subunits are expressed in anterior pituitary cells. The protein expression of HCN2, HCN3, and HCN4 in pituitary cells and GH3 lactosomatotrophs was confirmed using Western blot analysis. The apparent molecular weights corresponded to those previously reported for HCN subunits (Refs. 20 and 21 and references within). HCN2 and HCN3 appeared as doublets, probably due to posttranslational glycosylation (21). Protein expression of HCN1 could not be demonstrated, consistent with the low level of HCN1-mRNA transcript product and might reflect a cell type-specific expression pattern of HCN subunits in endocrine pituitary cells.

Furthermore, three lines of evidence suggested that pituitary lactotrophs, somatotrophs, thyrotrophs, and gonadotrophs, as well as other unidentified endocrine pituitary cells, express functional HCN channels. First, pituitary cells developed a slow-activating inward current upon hyperpolarization to a value of −60 mV or more negative. Second, the biophysical properties of this current (activation of this current by hyperpolarizing voltages, time course of activation, lack of inactivation during sustained recording, rapid deactivation, and activation curve obtained by tail current analysis) are consistent with the expression of these channels. Third, pharmacological profile of this current (reversible inhibition by 1 mm Cs+ and slow and irreversible inhibition by ZD7288) also supports the functional expression of HCN channels in endocrine pituitary cells, as was shown previously in other neuroendocrine cell types (49).

The majority of gonadotrophs, thyrotrophs, and somatotrophs express HCN channels. On the other hand, these channels were present in only a fraction of lactotrophs, which is consistent with the functional heterogeneity of these prolactin-producing cells (50, 51). What is the role of these channels in pituitary cell functions? Although the current density was relatively low in both normal and immortalized pituitary cells, such a current may still profoundly influence the resting membrane potential because pituitary cells are small and the input resistance of these cells is usually more than 5 GΩ. The contribution of the Ih current to the resting membrane conductance under normal ion concentrations was confirmed in experiments with hyperpolarizing current injection in gonadotrophs. In these cells, the voltage response to a hyperpolarizing current pulse showed slowly developing inward rectification, which was blocked by extracellular Cs+ and was absent in cells lacking Ih. This could indicate that Ih currents in pituitary cells may contribute to set the resting membrane potential in the range where other channels could account for the slow depolarization. It is important to stress that our experiments were done in isolated pituitary cells in vitro, and that in vivo these cells are organized as a large-scale network (52). The existence of such network, however, does not argue against the relevance of voltage-gated Ca2+ influx in rapid hormone release (48). Thus, it is reasonable to speculate that the operation of HCN channels is also preserved in interconnected cells.

Based on experiments with MDL12330A, an inhibitor of adenylyl cyclase, we also concluded that the basal cyclic nucleotide production in the majority of pituitary cells in vitro is high enough to partially or fully activate the Ih current. A similar effect was also observed using MDL12330A in GH3 cells and was overcome by the subsequent application of forskolin (14). This also explains the relatively weak effect of forskolin on Ih activation. We also frequently observed a decrease in the AP frequency in spontaneously firing cells with inhibited Ih, indicating that these channels contribute to the electrical activity in a manner comparable to that observed in GnRH neurons (49). In none of our experiments we observed abolition of spontaneous electrical activity, further indicating the role of other channels in slow depolarization. Among others, the background Na+ conductance is present in all endocrine pituitary cells (5355) and contributes to spontaneous electrical activity and accompanied Ca2+ transients (38). Basal cAMP production is down-regulated in vivo by several hypothalamic and intrapituitary factors, including dopamine and somatostatin (1), which suggest that facilitation of adenylyl cyclase activity in physiological conditions should lead to activation of HCN channels and firing of AP.

The activity of these channels is not only determined by the status of adenylyl cyclase activity, but also affected by Gq/11-coupled receptors signaling through phospholipase C pathway. Here we show that pharmacological activation of this enzyme leads to inhibition of Ih in gonadotrophs. Activation of GnRH receptors also causes inhibition of Ih. Experiments with wortmannin further indicated the potential role of PIP2 in the regulation of these channels in gonadotrophs. This is consistent with numerous reports about the requirement of PIP2 for HCN function (8, 56). Thus, it is reasonable to suggest that the Gq/11-coupled receptor-mediated shift from spontaneous electrical activity and Ca2+ influx to Ca2+ mobilization from intracellular pools is accompanied by a silencing of electrical activity mediated not only by the activation of apamin-sensitive K+ channels (23, 24) but also by the inhibition of HCN channels.

In conclusion, here we show that cAMP and cGMP exhibit opposite effects on the excitability of isolated endocrine pituitary cells; cGMP inhibits whereas cAMP stimulates electrical activity. We further show that the majority of pituitary gonadotrophs, thyrotrophs, somatotrophs, and a fraction of lactotrophs express HCN channels with biophysical, pharmacological, and immunoreactive properties comparable to those observed in other excitable cells expressing HCN channels. In cultured cells, basal adenylyl cyclase activity is sufficient to activate these channels, leading to facilitation of spontaneous firing of AP, and further stimulation of this enzyme enhances HCN channel activity. In contrast, activation of phospholipase C inhibits Ih current, presumably by depleting plasma membrane PIP2 levels. In vivo, these channels may contribute to facilitated electrical activity and enhanced hormone release by activated Gs-coupled receptors and may play an important role in restoration of electrical activity in lactotrophs and somatotrophs after removal of their respective inhibitory cues, dopamine and somatostatin.

Materials and Methods

Chemicals

TRH, GnRH, GHRH, and somatostatin were purchased from Bachem (Torrance, CA), MDL12330A and 3,3′-(hydroxynitrosohydrazino) bis-1-propanamine from Alexis Biochemicals (San Diego, CA), and apomorphine, bromocryptine mesylate, tetrodotoxin, and ZD7288 were obtained from Tocris (Ellisville, MO). All other drugs and chemicals were purchased from Sigma (St. Louis, MO).

Cell cultures

Experiments were performed on anterior pituitary cells from normal postpubertal female Sprague Dawley rats obtained from Taconic Farms (Germantown, NY). Euthanasia was performed by asphyxiation with CO2, and the anterior pituitary glands were removed after decapitation. Experiments were approved by the National Institute of Child Health and Human Development (NICHD) Animal Care and Use Committee. Anterior pituitary cells were mechanically dispersed after treatment with trypsin and cultured as mixed cells or enriched fractions in medium 199 containing Earle's salts, sodium bicarbonate, 10% heat-inactivated horse serum, penicillin (100 U/ml), and streptomycin (100 μg/ml), as described previously (57).

RT-PCR analysis of HCN isoform expression

Analysis of relative gene expression was done using real-time quantitative PCR and the comparative Ct method (19). For this purpose the predesigned Taq-Man Gene Expression Assays with LightCycler TaqMan Master mix (Applied Biosystems, Foster City, CA) and Lightcycler 2.0 Real-time PCR system (Roche, Indianapolis, IN) were used. To compare the relative expression levels of individual HCN channels, the levels were calibrated against HCN2 (set to 100%). Applied Biosystems predesigned Taq-Man Gene Expression Assays were used: for HCN1, Rn00584498_m1; HCN2, Rn01408572_mH; HCN3, Rn00586666_m1; HCN4, Rn00572232_m1; and GAPDH, Rn01462662_g1.

Western blot analysis of HCN channel isoforms

Primary pituitary cells or GH3 cells in culture were lysed in radioimmunoprecipitation assay buffer containing 50 mm Tris HCl (pH 7.4), 150 mm NaCl, 1% Nonider P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, and supplemented with protease inhibitors. Samples were separated by Tris-glycine SDS-PAGE and transferred onto polyvinylidene difluoride membranes. The membrane was blocked for 1 h at room temperature and then incubated overnight at 4 C with one of the primary antibodies: anti-HCN2 [Abcam, Inc., Cambridge, MA; antibody (ab)19346], anti-HCN3 (Abcam, ab109807), or anti-HCN4 (Abcam, ab69054), all diluted 1:1000, or anti-β-tubulin I antibody (Sigma Aldrich, T7816) diluted 1:10000. All incubations were performed in SuperBlock Blocking Buffer (Thermo Fisher Scientific. Pittsburgh, PA) supplemented with 0.1% Tween-20. After incubation with peroxidase-conjugated goat antirabbit (HCN2 and -4) or donkey antigoat secondary antibody (HCN3) diluted 1:10000 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), blots were incubated with SuperSignal West Pico Chemiluminescent Substrate Kit (Thermo Fisher Scientific), and bands were visualized on FluorChem E Digital imaging System (ProteinSimple, San Jose, CA).

Cyclic nucleotide measurements

Cyclic nucleotide production was monitored using static cultures of anterior pituitary cells. Briefly, cells (1 million per well) were plated in 24-well plates in medium 199 and incubated overnight at 37 C under 5% CO2-air and saturated humidity. The following day, medium was removed, cells were washed and then stimulated at 37 C under 5% CO2-air and saturated humidity with 1 mm 3-isobutyl-1-methylxanthine. Cyclic nucleotides were measured in incubation medium by RIA using specific antisera provided by Albert Baukal (NICHD, Bethesda, MD). 125I-labeled cAMP and 125I-labeled cGMP tracers were purchased from PerkinElmer Life Sciences (Boston, MA).

Electrophysiological recordings

Membrane voltage potential and whole-cell currents were measured using amphotericine-perforated patch-clamp technique. All experiments were performed at room temperature. Cells cultured on 35-mm culture dishes (100,000 per dish) were washed twice before connecting to a relatively fast gravity-driven microperfusion system (ALA Scientific Instruments, Westbury, NY) with common outlet. Cells were continuously perfused with an extracellular solution containing: 150 mm NaCl, 3 mmKCl, 2 mm CaCl2, 1 mm MgCl2, 10 mm 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid, and 10 mm glucose starting from at least 10 min before recording at flow rate of approximately 2 ml/min. The pH was adjusted to 7.3 with NaOH. For voltage-clamp measurement of Ih currents, composition of extracellular solution was modified as follows: 113 mmNaCl, 20 mm KCl, and 20 mm tetraethylammonium chloride, 2 mmCaCl2, 1 mm MgCl2, 10 mm 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid, 10 mm glucose, 1 mm 4-aminopyridine, 1 mm BaCl2, 1 mm CdCl2, and 0.001 mm tetrodotoxin. Patch pipettes were pulled from borosilicate glass (World Precision Instruments, Sarasota, FL) and heat polished to a tip resistance of 5–7 mΩ. Pipette solution contained: 90 mm K-aspartate, 50 mm KCl, 3 mm MgCl2, and 10 mm 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid, with pH adjusted to 7.2 with KOH. Before measurement, amphotericine B was added to the pipette solution from a stock solution (20 mg/ml in dimethyl sulfoxide) to obtain a final concentration of 200 μg/ml. Current-clamp and voltage-clamp recordings were performed using Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA). Recordings started when series resistance dropped below 100 mΩ for current-clamp or 40 mΩ for voltage-clamp recordings. Series resistance was compensated by more than 50%. Membrane potentials were corrected on-line for liquid junction potential of 9.9 mV. A difference of 1.9 mV between junction potential of control extracellular solution and modified 20 mm KCl solution used for Ih current recording was neglected. In some voltage-clamp experiments, P/4 protocol was applied on line to subtract leak conductance from current traces. Drugs dissolved to final concentration in extracellular solution were delivered to recording chamber by the same perfusion system, and less than 200 msec was required for exchange solutions around the patched cells, as described previously (58).

Calculations

The amplitude of Ih was calculated by subtracting the instantaneous current amplitude from the steady-state current at the end of the test pulse to −120 mV. The density of Ih was calculated by dividing the current amplitude by the membrane capacitance for each given cell. To characterize Ih activation kinetics, current traces elicited at −120 mV were fitted by a single exponential function or by the sum of two exponentials, and weighted tau (τw) was calculated as follows: τw = (τ1*A1+ τ2*A2)/(A1+A2), where A1 and A2 are the relative amplitudes of the two exponential components. Activation curves were determined from plots of tail current amplitudes (measured at −40 mV) as a function of test voltage during 7-sec hyperpolarizing steps. Normalized amplitudes of tail currents I/Imax were then plotted against test voltage and fitted with the Boltzmann equation: I/Imax = 1/{1+exp[(Vtest − V1/2)/s]}, where Vtest is the hyperpolarizing step potential, V1/2 is the half-activation potential, and s is the slope factor. Data values are expressed as mean ± sem. Statistical comparisons were made using the one-sample Student's t test. Significance was set at P < 0.05 or higher.

Acknowledgments

This work was supported by the Intramural Research Program of the NICHD, NIH.

Disclosure Summary: The authors have nothing to disclose.

Footnotes

Abbreviations:
ab
Antibody
AP
action potential
8-Br-cAMP
8-bromo-cAMP
8-Br-cGMP
8-bromo-cGMP
CNG
cyclic nucleotide-gated
HCN
hyperpolarization-activated and cyclic nucleotide-gated
Ih
the hyperpolarization-activated cation current
MDL12330A
cis-N-(2-phenylcyclopenthyl)azacyclotridec-1-en-2amine HCl
PIP2
phosphatidylinositol 4,5-bisphosphate
s
slope factor.

References

  • 1. Stojilkovic SS, Tabak J, Bertram R. 2010. Ion channels and signaling in the pituitary gland. Endocr Rev 31:845–915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Van Goor F, Zivadinovic D, Martinez-Fuentes AJ, Stojilkovic SS. 2001. Dependence of pituitary hormone secretion on the pattern of spontaneous voltage-gated calcium influx. Cell type-specific action potential secretion coupling. J Biol Chem 276:33840–33846 [DOI] [PubMed] [Google Scholar]
  • 3. Hille B. 2001. Ion channels of excitable cells. Sunderland, MA: Sinauer Associates, Inc [Google Scholar]
  • 4. Craven KB, Zagotta WN. 2006. CNG and HCN channels: two peas, one pod. Annu Rev Physiol 68:375–401 [DOI] [PubMed] [Google Scholar]
  • 5. Gauss R, Seifert R, Kaupp UB. 1998. Molecular identification of a hyperpolarization-activated channel in sea urchin sperm. Nature 393:583–587 [DOI] [PubMed] [Google Scholar]
  • 6. Ishii TM, Takano M, Xie LH, Noma A, Ohmori H. 1999. Molecular characterization of the hyperpolarization-activated cation channel in rabbit heart sinoatrial node. J Biol Chem 274:12835–12839 [DOI] [PubMed] [Google Scholar]
  • 7. Frère SG, Kuisle M, Lüthi A. 2004. Regulation of recombinant and native hyperpolarization-activated cation channels. Mol Neurobiol 30:279–305 [DOI] [PubMed] [Google Scholar]
  • 8. Pian P, Bucchi A, Decostanzo A, Robinson RB, Siegelbaum SA. 2007. Modulation of cyclic nucleotide-regulated HCN channels by PIP(2) and receptors coupled to phospholipase C. Pflugers Arch 455:125–145 [DOI] [PubMed] [Google Scholar]
  • 9. Ludwig A, Zong X, Hofmann F, Biel M. 1999. Structure and function of cardiac pacemaker channels. Cell Physiol Biochem 9:179–186 [DOI] [PubMed] [Google Scholar]
  • 10. Kaupp UB, Seifert R. 2001. Molecular diversity of pacemaker ion channels. Annu Rev Physiol 63:235–257 [DOI] [PubMed] [Google Scholar]
  • 11. Robinson RB, Siegelbaum SA. 2003. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 65:453–480 [DOI] [PubMed] [Google Scholar]
  • 12. Biel M, Wahl-Schott C, Michalakis S, Zong XG. 2009. Hyperpolarization-activated cation channels: from genes to function. Physiol Rev 89:847–885 [DOI] [PubMed] [Google Scholar]
  • 13. Simasko SM, Sankaranarayanan S. 1997. Characterization of a hyperpolarization-activated cation current in rat pituitary cells. Am J Physiol Endocrinol Metab 272:E405–E414 [DOI] [PubMed] [Google Scholar]
  • 14. Kretschmannova K, Gonzalez-Iglesias AE, Tomić M, Stojilkovic SS. 2006. Dependence of hyperpolarisation-activated cyclic nucleotide-gated channel activity on basal cyclic adenosine monophosphate production in spontaneously firing GH3 cells. J Neuroendocrinol 18:484–493 [DOI] [PubMed] [Google Scholar]
  • 15. Liu YC, Wang YJ, Wu PY, Wu SN. 2009. Tramadol-induced block of hyperpolarization-activated cation current in rat pituitary lactotrophs. Naunyn Schmiedebergs Arch Pharmacol 379:127–135 [DOI] [PubMed] [Google Scholar]
  • 16. Tian L, Shipston MJ. 2000. Characterization of hyperpolarization-activated cation currents in mouse anterior pituitary, AtT20 D16:16 corticotropes. Endocrinology 141:2930–2937 [DOI] [PubMed] [Google Scholar]
  • 17. Mei YA, Soriani O, Castel H, Vaudry H, Cazin L. 1998. Adenosine potentiates the delayed-rectifier potassium conductance but has no effect on the hyperpolarization-activated Ih current in frog melanotrophs. Brain Res 793:271–278 [DOI] [PubMed] [Google Scholar]
  • 18. Tomić M, Koshimizu T, Yuan D, Andric SA, Zivadinovic D, Stojilkovic SS. 1999. Characterization of a plasma membrane calcium oscillator in rat pituitary somatotrophs. J Biol Chem 274:35693–35702 [DOI] [PubMed] [Google Scholar]
  • 19. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)) method. Methods 25:402–408 [DOI] [PubMed] [Google Scholar]
  • 20. Bakondi G, Pór A, Kovács I, Szucs G, Rusznák Z. 2009. Hyperpolarization-activated, cyclic nucleotide-gated, cation non-selective channel subunit expression pattern of guinea-pig spiral ganglion cells. Neuroscience 158:1469–1477 [DOI] [PubMed] [Google Scholar]
  • 21. Cho HJ, Staikopoulos V, Furness JB, Jennings EA. 2009. Inflammation-induced increase in hyperpolarization-activated, cyclic nucleotide-gated channel protein in trigeminal ganglion neurons and the effect of buprenorphine. Neuroscience 162:453–461 [DOI] [PubMed] [Google Scholar]
  • 22. Tsaneva-Atanasova K, Sherman A, van Goor F, Stojilkovic SS. 2007. Mechanism of spontaneous and receptor-controlled electrical activity in pituitary somatotrophs: experiments and theory. J Neurophysiol 98:131–144 [DOI] [PubMed] [Google Scholar]
  • 23. Kukuljan M, Stojilković SS, Rojas E, Catt KJ. 1992. Apamin-sensitive potassium channels mediate agonist-induced oscillations of membrane potential in pituitary gonadotrophs. FEBS Lett 301:19–22 [DOI] [PubMed] [Google Scholar]
  • 24. Tse A, Hille B. 1992. GnRH-induced Ca2+ oscillations and rhythmic hyperpolarizations of pituitary gonadotropes. Science 255:462–464 [DOI] [PubMed] [Google Scholar]
  • 25. Harris NC, Constanti A. 1995. Mechanism of block by ZD 7288 of the hyperpolarization-activated inward rectifying current in guinea pig substantia nigra neurons in vitro. J Neurophysiol 74:2366–2378 [DOI] [PubMed] [Google Scholar]
  • 26. Shin KS, Rothberg BS, Yellen G. 2001. Blocker state dependence and trapping in hyperpolarization-activated cation channels: evidence for an intracellular activation gate. J Gen Physiol 117:91–101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Gonzalez-Iglesias AE, Kretschmannova K, Tomic M, Stojilkovic SS. 2006. ZD7288 inhibits exocytosis in an HCN-independent manner and downstream of voltage-gated calcium influx in pituitary lactotrophs. Biochem Biophys Res Commun 346:845–850 [DOI] [PubMed] [Google Scholar]
  • 28. Charles AC, Piros ET, Evans CJ, Hales TG. 1999. L-type Ca2+ channels and K+ channels specifically modulate the frequency and amplitude of spontaneous Ca2+ oscillations and have distinct roles in prolactin release in GH3 cells. J Biol Chem 274:7508–7515 [DOI] [PubMed] [Google Scholar]
  • 29. Tomić M, Van Goor F, He ML, Zivadinovic D, Stojilkovic SS. 2002. Ca(2+)-mobilizing endothelin-A receptors inhibit voltage-gated Ca(2+) influx through G(i/o) signaling pathway in pituitary lactotrophs. Mol Pharmacol 61:1329–1339 [DOI] [PubMed] [Google Scholar]
  • 30. Kuryshev YA, Haak L, Childs GV, Ritchie AK. 1997. Corticotropin releasing hormone inhibits an inwardly rectifying potassium current in rat corticotropes. J Physiol 502:265–279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Lee AK, Tse A. 1997. Mechanism underlying corticotropin-releasing hormone (CRH) triggered cytosolic Ca2+ rise in identified rat corticotrophs. J Physiol 504:367–378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Chen C, Xu R, Clarke IJ, Ruan M, Loneragan K, Roh SG. 2000. Diverse intracellular signalling systems used by growth hormone-releasing hormone in regulating voltage-gated Ca2+ or K channels in pituitary somatotropes. Immunol Cell Biol 78:356–368 [DOI] [PubMed] [Google Scholar]
  • 33. Chen C, Clarke IJ. 1995. Modulation of Ca2+ influx in the ovine somatotroph by growth hormone-releasing factor. Am J Physiol Endocrinol Metab 268:E204–E212 [DOI] [PubMed] [Google Scholar]
  • 34. Takei T, Takano K, Yasufuku-Takano J, Fujita T, Yamashita N. 1996. Enhancement of Ca2+ currents by GHRH and its relation to PKA and [Ca2+]i in human GH-secreting adenoma cells. Am J Physiol Endocrinol Metab 271:E801–E807 [DOI] [PubMed] [Google Scholar]
  • 35. Chen C, Clarke IJ. 1995. Effects of growth hormone-releasing peptide-2 (GHRP-2) on membrane Ca2+ permeability in cultured ovine somatotrophs. J Neuroendocrinol 7:179–186 [DOI] [PubMed] [Google Scholar]
  • 36. Kato M. 1996. Growth hormone-releasing hormone augments voltage-gated Na+ current in cultured rat pituitary cells. Am J Physiol 270:C125–C130 [DOI] [PubMed] [Google Scholar]
  • 37. Yang SK, Wang K, Parkington H, Chen C. 2008. Involvement of tetrodotoxin-resistant Na+ current and protein kinase C in the action of growth hormone (GH)-releasing hormone on primary cultured somatotropes from GH-green fluorescent protein transgenic mice. Endocrinology 149:4726–4735 [DOI] [PubMed] [Google Scholar]
  • 38. Tomić M, Kucka M, Kretschmannova K, Li S, Nesterova M, Stratakis CA, Stojilkovic SS. 2011. Role of nonselective cation channels in spontaneous and protein kinase A-stimulated calcium signaling in pituitary cells. Am J Physiol Endocrinol Metab 301:E370–E379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Cabilla JP, Ronchetti SA, Nudler SI, Miler EA, Quinteros FA, Duvilanski BH. 2009. Nitric oxide sensitive-guanylyl cyclase subunit expression changes during estrous cycle in anterior pituitary glands. Am J Physiol Endocrinol Metab 296:E731–E737 [DOI] [PubMed] [Google Scholar]
  • 40. Kostic TS, Andric SA, Maric D, Stojilkovic SS, Kovacevic R. 1999. Involvement of inducible nitric oxide synthase in stress-impaired testicular steroidogenesis. J Endocrinol 163:409–416 [DOI] [PubMed] [Google Scholar]
  • 41. Kostic TS, Andric SA, Stojilkovic SS. 2001. Spontaneous and receptor-controlled soluble guanylyl cyclase activity in anterior pituitary cells. Mol Endocrinol 15:1010–1022 [DOI] [PubMed] [Google Scholar]
  • 42. Schubert R, Nelson MT. 2001. Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol Sci 22:505–512 [DOI] [PubMed] [Google Scholar]
  • 43. Van Goor F, Zivadinovic D, Stojilkovic SS. 2001. Differential expression of ionic channels in rat anterior pituitary cells. Mol Endocrinol 15:1222–1236 [DOI] [PubMed] [Google Scholar]
  • 44. Ceccatelli S, Hulting AL, Zhang X, Gustafsson L, Villar M, Hökfelt T. 1993. Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci USA 90:11292–11296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Duvilanski BH, Zambruno C, Seilicovich A, Pisera D, Lasaga M, Diaz MC, Belova N, Rettori V, McCann SM. 1995. Role of nitric oxide in control of prolactin release by the adenohypophysis. Proc Natl Acad Sci USA 92:170–174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Andric SA, Gonzalez-Iglesias AE, Van Goor F, Tomić M, Stojilkovic SS. 2003. Nitric oxide inhibits prolactin secretion in pituitary cells downstream of voltage-gated calcium influx. Endocrinology 144:2912–2921 [DOI] [PubMed] [Google Scholar]
  • 47. Lafont C, Desarménien MG, Cassou M, Molino F, Lecoq J, Hodson D, Lacampagne A, Mennessier G, El Yandouzi T, Carmignac D, Fontanaud P, Christian H, Coutry N, Fernandez-Fuente M, Charpak S, Le Tissier P, Robinson IC, Mollard P. 2010. Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function. Proc Natl Acad Sci USA 107:4465–4470 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Schaeffer M, Hodson DJ, Lafont C, Mollard P. 2011. Endocrine cells and blood vessels work in tandem to generate hormone pulses. J Mol Endocrinol 47:R59–R66 [DOI] [PubMed] [Google Scholar]
  • 49. Chu Z, Takagi H, Moenter SM. 2010. Hyperpolarization-activated currents in gonadotropin-releasing hormone (GnRH) neurons contribute to intrinsic excitability and are regulated by gonadal steroid feedback. J Neurosci 30:13373–13383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Lledo PM, Guerineau N, Mollard P, Vincent JD, Israel JM. 1991. Physiological characterization of two functional states in subpopulations of prolactin cells from lactating rats. J Physiol 437:477–494 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Castaño JP, Kineman RD, Frawley LS. 1996. Dynamic monitoring and quantification of gene expression in single, living cells: a molecular basis for secretory cell heterogeneity. Mol Endocrinol 10:599–605 [DOI] [PubMed] [Google Scholar]
  • 52. Bonnefont X, Lacampagne A, Sanchez-Hormigo A, Fino E, Creff A, Mathieu MN, Smallwood S, Carmignac D, Fontanaud P, Travo P, Alonso G, Courtois-Coutry N, Pincus SM, Robinson IC, Mollard P. 2005. Revealing the large-scale network organization of growth hormone-secreting cells. Proc Natl Acad Sci USA 102:16880–16885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Simasko SM. 1994. A background sodium conductance is necessary for spontaneous depolarizations in rat pituitary cell line GH3. Am J Physiol 266:C709–C719 [DOI] [PubMed] [Google Scholar]
  • 54. Sankaranarayanan S, Simasko SM. 1996. A role for a background sodium current in spontaneous action potentials and secretion from rat lactotrophs. Am J Physiol 271:C1927–C1934 [DOI] [PubMed] [Google Scholar]
  • 55. Kucka M, Kretschmannova K, Murano T, Wu CP, Zemkova H, Ambudkar SV, Stojilkovic SS. 2010. Dependence of multidrug resistance protein-mediated cyclic nucleotide efflux on the background sodium conductance. Mol Pharmacol 77:270–279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Zolles G, Klöcker N, Wenzel D, Weisser-Thomas J, Fleischmann BK, Roeper J, Fakler B. 2006. Pacemaking by HCN channels requires interaction with phosphoinositides. Neuron 52:1027–1036 [DOI] [PubMed] [Google Scholar]
  • 57. Koshimizu TA, Tomić M, Wong AO, Zivadinovic D, Stojilkovic SS. 2000. Characterization of purinergic receptors and receptor-channels expressed in anterior pituitary cells. Endocrinology 141:4091–4099 [DOI] [PubMed] [Google Scholar]
  • 58. Zemkova H, He ML, Koshimizu TA, Stojilkovic SS. 2004. Identification of ectodomain regions contributing to gating, deactivation, and resensitization of purinergic P2X receptors. J Neurosci 24:6968–6978 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Endocrinology are provided here courtesy of The Endocrine Society

RESOURCES